•
Jun 30, 2021

Milestone Pharmaceuticals Q2 2021 Earnings Report

Total Revenue
$15M
EPS
$0.02
Previous year: -$0.53
-103.8%
Cash and Equivalents
$97.8M
Previous year: $53.4M
+83.0%
Total Assets
$145M
Previous year: $93.1M
+56.2%

Milestone Pharmaceuticals

Milestone Pharmaceuticals